Source:http://linkedlifedata.com/resource/pubmed/id/12456215
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-28
|
pubmed:abstractText |
Current tumor markers for ovarian cancer still lack adequate sensitivity and specificity to be applicable in large populations. High-throughput proteomic profiling and bioinformatics tools allow for the rapid screening of a large number of potential biomarkers in serum, plasma, or other body fluids.
|
pubmed:language |
eng
|
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1518-26
|
pubmed:dateRevised |
2004-11-17
|
pubmed:articleTitle |
Proteomic approaches to tumor marker discovery.
|
pubmed:affiliation |
Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Md 21287, USA.
|